About this trial
This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Primary Hip Prosthesis System in adult subjects undergoing primary hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.
Eligibility criteria
Qualifiers
Individuals aged 18 years and older,
Male or female participants,
Subjects who have undergone Primary Hip Arthroplasty (either total or partial) for any indication,
Subjects in whose surgical procedure the Tipmed™ Primary Hip Prosthesis System components were utilized.
Disqualifiers
Subjects currently participating in any other interventional clinical trial.
Trial design
Treatments tested in this trial
- Tipmed™ Primary Hip Prosthesis System